FDB (First Databank) vs Medi-Span (Wolters Kluwer) (2026)
Two of the drug data suppliers that prescribing, pharmacy and claims systems are built on. The first practical question is which one your systems already embed, because most buyers meet this content inside software they already run. The difference that matters for anyone building with AI is how each is repositioning. Both now run a Model Context Protocol server that lets other companies' agents query curated drug knowledge. FDB also ships AI products of its own, a prescription agent that queues orders for clinician review and a pharmacy order verification assistant. Medi-Span stays a grounding layer and publishes how its content is made: the sources, the size of the clinical team, the update cadence and the quality testing. FDB publishes none of that. FDB states its business associate role and Medi-Span states none. Neither publishes a security attestation of its own or a price.
- It ships AI products of its own on top of the content: Script Agent turns a spoken clinical conversation into structured orders queued for clinician review, and VerifyAssist supports inpatient pharmacy order verification.
- It states in its privacy notice that it acts as a HIPAA business associate for its customers, so the contractual starting point for patient data is published.
- Its drug databases are embedded in the systems used by most American hospitals, practices and pharmacies, so much of the medication content clinicians already see is FDB's.
- It publishes its editorial process: primary sources, a team of nearly 150 advanced degreed clinicians, daily surveillance of literature and industry activity, weekly updates on medication guides, REMS and shortages, and clinical quality testing against edge cases.
- Its clinical screening modules are itemized by input, taking age, weight, body surface area, renal function, conditions, pregnancy and lactation status and pharmacogenomic factors, with dose ranges for adult, pediatric and neonatal patients.
- Eligible Epic customers, including rural hospitals and federally qualified health centers, can take it inside Epic as part of a combined Wolters Kluwer offering with simplified procurement and implementation.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. FDB (First Databank) and Medi-Span (Wolters Kluwer) are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | FDB (First Databank) | Medi-Span (Wolters Kluwer) |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Headquarters | South San Francisco, California, United States | Waltham, Massachusetts, United States |
| Website | fdbhealth.com | wolterskluwer.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards FDB (First Databank) its top capability grade on EHR and Interoperability Depth. Set against Medi-Span (Wolters Kluwer), FDB (First Databank) grades higher on AI Centrality, HIPAA and BAA Posture and EHR and Interoperability Depth. Its thinnest published disclosure sits on Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
The AI Health Index records no top capability grade for Medi-Span (Wolters Kluwer) on any axis it scores. Set against FDB (First Databank), Medi-Span (Wolters Kluwer) grades higher on Model and Technology Transparency. Its thinnest published disclosure sits on AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, September 2026
Questions buyers ask
Should we choose FDB (First Databank) or Medi-Span (Wolters Kluwer)?
On the axes where the AI Health Index separates them, FDB (First Databank) grades higher on AI Centrality, HIPAA and BAA Posture and EHR and Interoperability Depth, and Medi-Span (Wolters Kluwer) grades higher on Model and Technology Transparency. FDB (First Databank) leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do FDB (First Databank) and Medi-Span (Wolters Kluwer) differ most?
The widest separation the AI Health Index records between FDB (First Databank) and Medi-Span (Wolters Kluwer) is on HIPAA and BAA Posture, where FDB (First Databank) grades B and Medi-Span (Wolters Kluwer) grades D. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do FDB (First Databank) and Medi-Span (Wolters Kluwer) grade the same?
The AI Health Index grades FDB (First Databank) and Medi-Span (Wolters Kluwer) the same on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have FDB (First Databank) and Medi-Span (Wolters Kluwer) not disclosed?
At the last review, at least one of FDB (First Databank) and Medi-Span (Wolters Kluwer) published thin or absent detail on AI Centrality, HIPAA and BAA Posture and Security Certifications and Trust Center. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Medication Safety & Prescribing page.
Neither publishes a price or a security attestation of its own. Wolters Kluwer publishes ISO 27001 and SOC 2 certification for products in other divisions, and those do not cover Medi-Span. FDB states its business associate role in its privacy notice. Medi-Span states no HIPAA position for its hosted screening APIs or its agent server, though customers who load its data files into their own systems send it nothing.
Medi-Span ships no AI model of its own, which is why its AI Centrality grade sits below FDB's; the grade describes the mechanism, not the quality of the content. Medi-Span's headline customer figures, 98 percent satisfied and 99 percent likely to renew, are published without method or sample. Neither publishes an evaluation of how faithfully downstream agents represent what its server returns.